Gains in engagement, conformal coverage, seamless logistics, planning, and procedural efficiency drive Wisconsin brachytherapy program’s transition to Cesium Blu™.
Physician Spotlight
The Big Reason Why One Team Switched to Cesium Blu Brachytherapy
“The potential to smooth out our workflow and increase our potential candidate pool for the procedure given the ability to do brachytherapy with Cesium Blu prior to EBRT is a compelling motivation for adding it to our prostate cancer treatment arsenal,”- Dr. Bobby...
Dr. Peter Orio Showcases the Elegance and Simplicity of Brachytherapy for Prostate Cancer
Photo curtesy of The Boston Herald. Boston Herald Reporter Alexi Cohan recently joined Dr. Peter Orio on the “front lines” in order to learn more about brachytherapy for prostate cancer treatment. This article details the brachytherapy procedure process and the...
Transitioning isotopes for prostate brachytherapy: Dr. Bernard Taylor, Texas Oncology
Transition concerns should not stop you from adding Cesium to your prostate brachytherapy practice. With a thoughtful approach to planning and the right support, you can seamlessly upgrade your prostate brachytherapy to the power of Cesium.
Prostate Cancer Research Institute: “The Importance of Knowing About All of Your Prostate Cancer Treatment Options”
“I urge newly diagnosed men to see a range of specialists before selecting treatment. After talking to a urologist, they should make independent appointments with a radiation oncologist, a medical oncologist, and a brachytherapist to ensure that they become fully...
Advantageous biological effect, Cesium-131’s short half-life, and new shielded or dynamically modulated sources: Dr. Mark Rivard’s thoughts on brachytherapy from ABS 2018
As a physicist, Dr. Mark Rivard is fascinated by brachytherapy’s ability to provide “conformal, localized” radiotherapy compared to external-beam radiation therapy for treatment of multiple cancer types.
The value of Cesium for brachytherapy treatment lies in its short half-life for Dr. R. Alex Hsi
Dr. R. Alex Hsi is a Radiation Oncologist at the Peninsula Cancer Center in Poulsbo, Washington. As a practitioner of various prostate radiation treatments like external beam radiation and stereotactic body radiation...
Nearly out of treatment options, Cesium-131 brachytherapy saved Barbara’s life
Dr. John Sheldon brought his experience with brachytherapy to bear with a targeted treatment for Barbie after her cervical cancer returned in 2015.
Biological effectiveness dose and convenience: Why Cesium-131 is the LDR brachytherapy isotope of choice for Dr. Bradley Prestidge.
Dr. Bradley Prestidge, MD, MS, serves as Regional Medical Director of Radiation Oncology for Bon Secours Medical Group in Norfolk, Va. During the American Brachytherapy Society 2018 Annual Meeting, Dr. Prestidge shared with us his opinion on brachytherapy’s top...
Dr. John Sylvester Explores the Many Advantages of the Prostate Brachytherapy Procedure Over Surgery at ABS 2018
According to Dr. Sylvester, brachytherapy provides many advantages over surgery for prostate cancer treatment. This underscores the importance of prostate cancer patients becoming aware of brachytherapy as a treatment option.
Sharpening the focus on focal therapy for prostate cancer treatment
To the benefit of patients and urologists worldwide, focal therapy for prostate cancer bridges the sizable gap between active surveillance and radical prostatectomy. Its ability to provide effective disease control, minimize the potential for chronic incontinence and...
UVA Today: “A Gold-Standard Cancer Treatment Is In Decline, And Money May Be Why”
Dr. Timothy Showalter, a radiation oncologist, led the study on why a potentially life-saving treatment for cervical cancer was being less utilized. (Photo by Josh Barney, UVA Health System) “The evidence is clear: Cervical cancer is best treated with brachytherapy, a...